ANI Pharmaceuticals Competitors and Similar CompaniesClear all
ANI Pharmaceuticals's competitors and similar companies include Dermavant Sciences, Merus and Allecra Therapeutics.
 ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. |  Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  Allecra Therapeutics Allecra is a biopharmaceutical company focused on the development of novel treatments to combat multi-drug-resistant bacterial infections. | |
Founding Date | Founding Date 1996 | Founding Date 2016 | Founding Date 2003 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations Utrecht, NL HQ Cambridge, US | Locations Hamburg, DE HQ Saint Louis, FR Lörrach, DE Detroit, US |
Employees | Employees 33813% increase | Employees 286 | Employees 172 | Employees 7 |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 3.6 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $486.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $43.9m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income $18.8m (FY, 2023) | Net income ($255.3m) (FY, 2019) | Net income ($154.9m) (FY, 2023) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 149.3m | Total funding raised $ 44.4m |
For sources of this data, please see the company profile
View Company Profiles
Dermavant Sciences
HQ
Long Beach, US
Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
View companyMerus
HQ
Utrecht, NL
Employees
172
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View companyAllecra Therapeutics
HQ
Hamburg, DE
Employees
7
Allecra is a biopharmaceutical company focused on the development of novel treatments to combat multi-drug-resistant bacterial infections.
View company